Against this background, the high rates of hypoglycaemia observed in patients treated with insulin in comparison to those administered incretin-based therapies in the DiaRegis study are noteworthy, with an OR of 11.45 for symptomatic hypoglycaemia and 8.33 for asymptomatic hypoglycaemia. This evidence concerns the gene INS and Hypoglycemia.